<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Effect of mesenchymal stem cells therapy in experimental kaolin induced syringomyelia model

dc.contributor.authorBal, Ercan
dc.contributor.authorHanalioglu, Sahin
dc.contributor.authorKopru, Cagla Z.
dc.contributor.authorKose, Sevil
dc.contributor.authorBasak, Ahmet T.
dc.contributor.authorPehlivan, Sibel B.
dc.contributor.authorBozkurt, Gokhan
dc.date.accessioned2026-10-09T21:51:50Z
dc.date.issued2022
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractBACKGROUND: Syringomyelia is a pathological cavitation of the spinal cord. In this study, we examined whether a syrinx cavity would limit itself with axonal regeneration and stem cell activity in the cavity, and we evaluated subjects on a functional basis. METHODS: Groups were designated as kaolin, trauma, kaolin-trauma, and saline groups. Also divided out of the syringomyelia treated groups were those given human mesenchymal stem cells (hMSCs). All groups were evaluated with immunohistochemistry, electron microscopy, confocal microscopy and functionally. RESULTS: The kaolin-trauma group had a significant correction of BBB score with hMSCs therapy. The syrinx cavity measurements showed significant improvement in groups treated with hMSCs. The tissue surrounding the syrinx cavity, however, appeared to be better organized in groups treated with hMSCs. The process of repair and regeneration of damaged axons in the lesion were more improved in groups treated with hMSCs. Using confocal microscopy, fluorescence of hMSCs was observed in the central canal, in the ependymal tissue, and around the lesion. CONCLUSIONS: It was concluded that axonal repair accelerated in groups receiving stem cells, and thus, stem cells may be effective in recovery of neural tissue and myelin damage in syringomyelia.
dc.identifier.doi10.23736/S0390-5616.20.05026-2
dc.identifier.endpage48
dc.identifier.issn0390-5616
dc.identifier.issn1827-1855
dc.identifier.issue1
dc.identifier.orcid0000-0003-4988-4938
dc.identifier.orcid0000-0003-3593-6493
dc.identifier.pmid33056946
dc.identifier.scopus2-s2.0-85125014643
dc.identifier.scopusqualityQ2
dc.identifier.startpage40
dc.identifier.urihttps://doi.org/10.23736/S0390-5616.20.05026-2
dc.identifier.urihttps://hdl.handle.net/20.500.12794/3871
dc.identifier.volume66
dc.identifier.wosWOS:000761303300004
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.digerScience Citation Index Expanded (SCI-EXPANDED)
dc.language.isoen
dc.publisherEdizioni Minerva Medica
dc.relation.ispartofJournal of Neurosurgical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260922
dc.subjectConfocal Microscopy
dc.subjectKaolin
dc.subjectMesenchymal Stem Cells
dc.subjectSyringomyelia
dc.titleEffect of mesenchymal stem cells therapy in experimental kaolin induced syringomyelia model
dc.typeArticle

Files